Multiplex Polymerase Chain Reaction (PCR)
Cystic Fibrosis mutation panel for general population screening. This assay may be used for determination of carrier status in individuals who have a family history of cystic fibrosis, and refinement of carrier risk for those individuals who do not have a family history of cystic fibrosis. This panel includes genotyping for 60 mutations and variants within the CFTR gene. See http://www.pathology.med.umich.edu/handbook/Tables/INPLX_Mutations.pdf for complete listing of the tested mutations and variants.
Interpretive report provided.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
This test will not detect mutations other than the 60 described above. The accuracy of reported probabilities are contingent upon the accuracy of the history provided. This test is intended only for carrier screening, not for the diagnosis of cystic fibrosis.
3 - 10 days
- CYSTIC FIBROSIS CARRIER SCREEN
- Sweat Chloride
- Cystic Fibrosis Mutation
- CF Carrier Screening Mutation Detection
- CFTR Mutation Screening
Collect blood in a lavender top tube. Refrigerate and send intact blood specimen within 48 hours of collection.
By ordering this test the clinician acknowledges that informed consent has been obtained from the patient as required by applicable state or federal laws and the ordering clinician has authorization from the patient permitting MLabs to report the test results to the ordering clinician. Test includes pathologist interpretation of results billed as a separate additional charge. This test is not available without interpretation.